FDA Warns Millions to Stop Using Faulty Glucose Monitors Linked to Deaths and Injuries
The US Food and Drug Administration (FDA) has issued a warning to millions of glucose monitor users after discovering that certain devices made by Abbott Diabetes Care were producing inaccurate readings, resulting in seven reported deaths and over 700 injuries. The faulty sensors were found to provide incorrect low glucose readings, which can lead people with diabetes to make life-threatening decisions such as consuming excessive carbohydrates or delaying insulin doses.
The affected sensors were part of the FreeStyle Libre 3 and FreeStyle Libre 3 Plus devices, which measure glucose levels in fluid just beneath the skin. The devices send wireless data to a user's device or phone, but some sensors produced inaccurate readings, posing serious health risks.
The FDA has identified over three million sensors from one production line as potentially affected, with about half of them already expired or used up. Globally, seven deaths have been reported and 736 serious adverse events documented, although no fatalities occurred in the US where only 57 injuries were recorded.
Abbott Diabetes Care has notified all customers of the issue and has identified and resolved the problem in the affected production lot. The FDA advises users to stop using affected sensors and discard them immediately.
Users can visit Abbott's website to check if their sensors are potentially affected and request a replacement. However, it's essential to note that only certain FreeStyle Libre products are affected, and no other devices are impacted.
The recall has significant implications for millions of people worldwide who rely on these glucose monitors for their daily lives. The FDA's warning serves as a reminder of the importance of regular monitoring and maintenance of medical devices to ensure safety and efficacy.
The US Food and Drug Administration (FDA) has issued a warning to millions of glucose monitor users after discovering that certain devices made by Abbott Diabetes Care were producing inaccurate readings, resulting in seven reported deaths and over 700 injuries. The faulty sensors were found to provide incorrect low glucose readings, which can lead people with diabetes to make life-threatening decisions such as consuming excessive carbohydrates or delaying insulin doses.
The affected sensors were part of the FreeStyle Libre 3 and FreeStyle Libre 3 Plus devices, which measure glucose levels in fluid just beneath the skin. The devices send wireless data to a user's device or phone, but some sensors produced inaccurate readings, posing serious health risks.
The FDA has identified over three million sensors from one production line as potentially affected, with about half of them already expired or used up. Globally, seven deaths have been reported and 736 serious adverse events documented, although no fatalities occurred in the US where only 57 injuries were recorded.
Abbott Diabetes Care has notified all customers of the issue and has identified and resolved the problem in the affected production lot. The FDA advises users to stop using affected sensors and discard them immediately.
Users can visit Abbott's website to check if their sensors are potentially affected and request a replacement. However, it's essential to note that only certain FreeStyle Libre products are affected, and no other devices are impacted.
The recall has significant implications for millions of people worldwide who rely on these glucose monitors for their daily lives. The FDA's warning serves as a reminder of the importance of regular monitoring and maintenance of medical devices to ensure safety and efficacy.